Only 5/22 (32%) of the patients suffered from thrombosis before the first dosing of asparaginase and the Cox regression analysis showed a clear association of asparaginase treatment with occurrence of truncal or CVL VTs (χ2: 6.850, P = 0.0089). This evidence concerns the gene ASPG and Venous thrombosis.